3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
8
Stomach Neoplasms
3
Rectal Neoplasms
3
Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Hepatocellular
3
Prostatic Neoplasms
2
Pancreatic cancer, adult
2
Lung Neoplasms
2
Recurrence
1
Pancreatic carcinoma, familial
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Metabolic Syndrome
1
Liver Cirrhosis
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia
1
Glioblastoma
1
Fibrosis
1
Fatigue
1
Esophageal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Fluorouracil
67
Radiotherapy
53
Cisplatin
52
Oxaliplatin
47
Leucovorin
37
Paclitaxel
36
Irinotecan
27
Docetaxel
23
Capecitabine
20
Nivolumab
17
Carboplatin
16
pembrolizumab
15
Radiation
15
Neoadjuvant Therapy
15
Surgical Procedures, Operative
12
Cetuximab
12
durvalumab
9
Drug Therapy
9
Biopsy
9
Taxes
8
Folfox protocol
8
Chemotherapy, Adjuvant
8
Trastuzumab
7
Magnetic Resonance Spectroscopy
7
Gefitinib
7
Endoscopy
7
tremelimumab
6
Specimen Handling
6
Endoscopy, Digestive System
6
Ramucirumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Hematologic Tests
×
Gastrointestinal
×
Clear all
NCT02610764
2017-04-13
ESO-CTC
University Hospital Freiburg
Phase NA
Completed
19 enrolled